.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Teva
Julphar
Boehringer Ingelheim
Harvard Business School
Baxter
Mallinckrodt
Daiichi Sankyo
Chubb
McKinsey

Generated: February 19, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0706744.0

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Avanir PharmsONZETRA XSAILsumatriptan succinatePOWDER;INHALATION206099-001Jan 27, 2016RXYesYes➤ Sign Up➤ Sign UpYMETHOD OF DRUG DELIVERY VIA THE NASAL CAVITY
Avanir PharmsONZETRA XSAILsumatriptan succinatePOWDER;INHALATION206099-001Jan 27, 2016RXYesYes➤ Sign Up➤ Sign UpYTREATMENT OF MIGRAINE VIA DELIVERY OF SUMATRIPTAN VIA THE NASAL CAVITY
Avanir PharmsONZETRA XSAILsumatriptan succinatePOWDER;INHALATION206099-001Jan 27, 2016RXYesYes➤ Sign Up➤ Sign UpYACUTE TREATMENT OF MIGRAINE BY DELIVERING A POWDERED SUBSTANCE COMPRISING SUMATRIPTAN VIA A BREATH-POWERED DELIVERY DEVICE
Avanir PharmsONZETRA XSAILsumatriptan succinatePOWDER;INHALATION206099-001Jan 27, 2016RXYesYes➤ Sign Up➤ Sign UpYACUTE TREATMENT OF MIGRAINE
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist